|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/519 | (2006.01) |
| A61K 31/215 | (2006.01) | ||
| A61K 45/06 | (2006.01) | ||
| A61P 31/14 | (2006.01) |
| (11) | Number of the document | 2627334 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11833515.7 |
| Date of filing the European patent application | 2011-10-14 | |
| (97) | Date of publication of the European application | 2013-08-21 |
| (45) | Date of publication and mention of the grant of the patent | 2015-04-29 |
| (46) | Date of publication of the claims translation | 2015-07-27 |
| (86) | Number | PCT/US2011/056421 |
| Date | 2011-10-14 |
| (87) | Number | WO 2012/051570 |
| Date | 2012-04-19 |
| (30) | Number | Date | Country code |
| 393522 P | 2010-10-15 | US | |
| 201161492054 P | 2011-06-01 | US |
| (72) |
BANTIA, Shanta, US
KOTIAN, Pravin, L., US
BABU, Yarlagadda, S., US
|
| (73) |
Biocryst Pharmaceuticals, Inc.,
4505 Emperor Blvd., Durham, North Carolina 27703,
US
|
| (74) |
Liucija JANICKAITĖ,
Inpatra UAB, Šeškinės g. 59-53, LT-07162 Vilnius,
LT
|
| (54) | Kompozicijos, skirtos naudoti virusinių infekcijų gydymui |
| COMPOSITIONS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS |
| Payment date | Validity (years) | Amount | |
| 2025-09-17 | 15 | 289.00 EUR |
| 2026-10-14 |